Abba M, Behbod F, Ceppi P, Chammas R, Clarke R, Dalotto T, De Siervi A, Gómez-Abuin G, Gottifredi V, Hoadley KA, Jerry J, Juric D, Kordon E, Lanari C, Lee A, Mahmoud YD, Mandó P, Maurer J, Mauro F, Miller T, Muller WJ, Novaro V, Oesterreich S, Park C, Pettit S, Razavi P, Richer J, Roqué M, Rossi M, Salaberry PJ, Salatino M, Sciacca M, Vallone SA, Vilarullo RN, Vivanco M, Waisberg F, Welm A, Wolos VJ. Buenos Aires Breast Cancer Symposium 2024: bridging basic and clinical research in breast cancer. Medicina (Buenos Aires). 2025;85(3):586-596. https://www.medicinabuenosaires.com/PMID/40577145.pdf Ocassional article

Calzetta NL, Mansilla SF, Mares-Ahlers MC, Bertolin AP, Caimi LI, Venerus-Arbilla S, Zeng J, Wiesmüller L, Gottifredi V. Endogenous p21 levels protect genomic stability by suppressing both excess and restrained nascent DNA syntheses. Science Advances. 2025;11(41):eadw4618. https://doi.org/10.1126/sciadv.adw4618 Research article PubMed

Okraine YV, de la Vega MB, Venerus-Arbilla S, Moyano G, Bertolin AP, Pallarés HM, Wiesmüller L, Mansilla SF, Gottifredi V. Versatile enhancement of the killing potential of anti-cancer agents achieved by peptide mimetics of the PCNA interface towards specialized DNA polymerases. Cell Death & Disease. 2025;16(1):503. https://doi.org/10.1038/s41419-025-07812-9 Research article PubMed

Siri SO, Abramovici-Blasco A, Moyano G, Mares-Ahlers MC, Gottifredi V. All roads lead to mitosis: A common requirement for DNA replication stress-dependent and -independent killing of BRCA-deficient cells. Mutation Research. Reviews in Mutation Research. 2025;796:108557. https://doi.org/10.1016/j.mrrev.2025.108557 Review PubMed

Vilarullo R, Casco MDP, Mares-Ahlers MC, Gottifredi V, Balcone L, Maggio J, Mengual-Gómez DL, Gómez DE, Armando RG. Improving therapeutic strategies for triple-negative breast cancer: synergistic effects of DKC1 inhibition and paclitaxel. Expert Opinion on Therapeutic Targets. 2025;29(7):491-504. https://doi.org/10.1080/14728222.2025.2537416 Research article PubMed

Bertolin AP, Gottifredi V. A mitotic stopwatch determines cell fate. Science. 2024;383(6690):1414-1415. https://doi.org/10.1126/SCIENCE.ADO5703  Comment  PubMed

Castaño BA, Schorer S, Guo Y, Calzetta NL, Gottifredi V, Wiesmüller L, Biber S. The levels of p53 govern the hierarchy of DNA damage tolerance pathway usage. Nucleic Acids Research. 2024;52(7):3740-3760. https://doi.org/10.1093/nar/gkae061 Research article  PubMed

Jahjah T, Singh JK, Gottifredi V, Quinet A. Tolerating DNA damage by repriming: Gap filling in the spotlight. DNA Repair. 2024;142:103758. https://doi.org/10.1016/j.dnarep.2024.103758 Research article PubMed

Montero L, Okraine YV, Orlowski J, Matzkin S, Scarponi I, Miranda MV, Nusblat A, Gottifredi V, Alonso LG. Conserved cysteine-switches for redox sensing operate in the Cyclin-Dependent Kinase Inhibitor p21(CIP/KIP) Protein Family. Free Radical Biology & Medicine. 2024;224:494-505. https://doi.org/10.1016/j.freeradbiomed.2024.09.013  Research article  PubMed

Guantay L, Garro C, Siri S, Pansa MF, Ghidelli-Disse S, Paviolo N, Racca A, Nicotra V, Radu C, Bocco JL, Felice R, Jansson KH, Remlinger K, Amador A, Stronach E, Coleman K, Muelbaier M, Drewes G, Gloger I, Madauss K, García M, Gottifredi V, Soria G. Deoxycytidine kinase (dCK) inhibition is synthetic lethal with BRCA2 deficiency. Drug Resistance Updates. 2023;67:100932. https://doi.org/10.1016/j.drup.2023.100932  Research article PubMed

Mansilla SF, Bertolin AP, Venerus-Arbilla S, Castaño BA, Jahjah T, Singh JK, Siri SO, Castro MV, de la Vega MB, Quinet A, Wiesmüller L, Gottifredi V. Polymerase iota (Pol ι) prevents PrimPol-mediated nascent DNA synthesis and chromosome instability. Science Advances. 2023:9(15):eade7997. https://doi.org/10.1126/sciadv.ade7997 Research article  PubMed

Martino J, Siri SO, Calzetta NL, Paviolo NS, Garro C, Pansa MF, Carbajosa S, Brown AC, Bocco JL, Gloger I, Drewes G, Madauss KP, Soria G, Gottifredi V. Inhibitors of Rho kinases (ROCK) induce multiple mitotic defects and synthetic lethality in BRCA2-deficient cells. eLife. 2023;12:e80254. https://doi.org/10.7554/elife.80254 Research article  PubMed

Calzetta NL, Besteiro MAG, Gottifredi V. PARP activity fine-tunes the DNA replication choreography of Chk1-depleted cells. Journal of Molecular Biology. 433(10):166949. https://doi.org/10.1016/j.jmb.2021.166949   Communication   PubMed

Ihle M, Biber S, Schroeder IS, Blattner C, Deniz M, Damia G, Gottifredi V, Wiesmüller L. Impact of the interplay between stemness features, p53 and pol iota on replication pathway choices. Nucleic Acids Research. 2021;49(13):7457-7475. https://doi.org/10.1093/nar/gkab526  Research article  PubMed

Siri SO, Martino J, Gottifredi V. Structural chromosome instability: Types, origins, consequences, and therapeutic opportunities. Cancers. 2021;13(12):3056. https://doi.org/10.3390/cancers13123056  Review  PubMed